{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:33:19Z","timestamp":1792683199537,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274074"],"award-info":[{"award-number":["82274074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204426"],"award-info":[{"award-number":["82204426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230157"],"award-info":[{"award-number":["BK20230157"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor-derived elements contribute to the formation of the pre-metastatic niche (PMN) and facilitate cancer metastasis, but much less is known about the key molecular mechanisms. Here, we demonstrate that collapsin response mediator protein 2 (CRMP2), a critical regulator of the cytoskeleton, is associated with metastasis in breast cancer. CRMP2 overexpression inhibits both lung metastasis and PMN formation in breast cancer. Mechanistically, CRMP2 overexpression leads to downregulation of CXCL10. We also found that the correlation between CRMP2 and CXCL10 is mediated by interleukin enhancer-binding factor 3 (ILF3). The D-hydantoinases (D-HYD) fragment of CRMP2 specifically interacts with the second double-stranded RNA binding motif (dsRBM2) of ILF3. Overexpressed CRMP2 reduces the expression of ILF3 in proteasome-dependent degradation via Lys 48-linked polyubiquitination at Lys\n                    <jats:sup>257<\/jats:sup>\n                    , Lys\n                    <jats:sup>332<\/jats:sup>\n                    and Lys\n                    <jats:sup>413<\/jats:sup>\n                    . In addition, ILF3 directly binds to CXCL10 mRNA, thereby increasing CXCL10 mRNA stability. Finally, we found that psoralen interacts with CRMP2 and suppresses the development of lung metastases in breast cancer. In conclusion, our findings uncover a critical CRMP2-related mechanism behind breast tumor metastasis, and the CRMP2-ILF3-CXCL10 axis may provide a potential therapeutic strategy for controlling breast cancer metastasis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08515-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:48:30Z","timestamp":1771919310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CRMP2 inhibits metastasis formation by impairing ILF3-dependent stabilization of CXCL10 mRNA in breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Binyan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-2067","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5392-1896","authenticated-orcid":false,"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7281-210X","authenticated-orcid":false,"given":"E-Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"8515_CR1","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397:1750\u201369.","journal-title":"Lancet"},{"key":"8515_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8515_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"8515_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(24)00747-5","volume":"403","author":"CE Coles","year":"2024","unstructured":"Coles CE, Earl H, Anderson BO, Barrios CH, Bienz M, Bliss JM, et al. The Lancet Breast Cancer Commission. Lancet. 2024;403:1895\u2013950.","journal-title":"Lancet"},{"key":"8515_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","volume":"26","author":"AW Lambert","year":"2024","unstructured":"Lambert AW, Zhang Y, Weinberg RA. Cell-intrinsic and microenvironmental determinants of metastatic colonization. Nat Cell Biol. 2024;26:687\u201397.","journal-title":"Nat Cell Biol"},{"key":"8515_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"8515_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820\u20137.","journal-title":"Nature"},{"key":"8515_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189081","volume":"1879","author":"H Xie","year":"2024","unstructured":"Xie H, Sun Q, Chu X, Zhu S, Xie F. Review of pre-metastatic niches in lung metastasis: from cells to molecules, from mechanism to clinics. Biochim Biophys Acta Rev Cancer. 2024;1879:189081.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8515_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17:302\u201317.","journal-title":"Nat Rev Cancer"},{"key":"8515_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016;30:668\u201381.","journal-title":"Cancer Cell"},{"key":"8515_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.05.003","volume":"93","author":"M Hu","year":"2023","unstructured":"Hu M, Kenific CM, Boudreau N, Lyden D. Tumor-derived nanoseeds condition the soil for metastatic organotropism. Semin Cancer Biol. 2023;93:70\u201382.","journal-title":"Semin Cancer Biol"},{"key":"8515_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.65227","volume":"18","author":"C Zhou","year":"2022","unstructured":"Zhou C, He X, Tong C, Li H, Xie C, Wu Y, et al. Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop. Int J Biol Sci. 2022;18:1363\u201380.","journal-title":"Int J Biol Sci"},{"key":"8515_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejca.2021.01.011","volume":"147","author":"S Wu","year":"2021","unstructured":"Wu S, Xing X, Wang Y, Zhang X, Li M, Wang M, et al. The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism. Eur J Cancer. 2021;147:63\u201373.","journal-title":"Eur J Cancer"},{"key":"8515_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cell.2004.11.012","volume":"120","author":"T Yoshimura","year":"2005","unstructured":"Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell. 2005;120:137\u201349.","journal-title":"Cell"},{"key":"8515_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.20465","volume":"486","author":"S Bretin","year":"2005","unstructured":"Bretin S, Reibel S, Charrier E, Maus-Moatti M, Auvergnon N, Thevenoux A, et al. Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J Comp Neurol. 2005;486:1\u201317.","journal-title":"J Comp Neurol"},{"key":"8515_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/cells11040727","volume":"11","author":"YH Chang","year":"2022","unstructured":"Chang YH, Yang HJ, Chen HW, Hsiao CW, Hsieh YC, Chan YW, et al. Characterization of collapsin response mediator protein 2 in colorectal cancer progression in subjects with diabetic comorbidity. Cells. 2022;11:727.","journal-title":"Cells"},{"key":"8515_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76951-0","volume":"10","author":"M Noura","year":"2020","unstructured":"Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, et al. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells. Sci Rep. 2020;10:20245.","journal-title":"Sci Rep"},{"key":"8515_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cell.2020.09.064","volume":"183","author":"IH Guldner","year":"2020","unstructured":"Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, et al. CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10. Cell. 2020;183:1234\u20131248.e1225.","journal-title":"Cell"},{"key":"8515_CR19","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1158\/0008-5472.CAN-12-0481","volume":"72","author":"JH Lee","year":"2012","unstructured":"Lee JH, Kim HN, Kim KO, Jin WJ, Lee S, Kim HH, et al. CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res. 2012;72:3175\u201386.","journal-title":"Cancer Res"},{"key":"8515_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.676135","volume":"11","author":"AM Clark","year":"2021","unstructured":"Clark AM, Heusey HL, Griffith LG, Lauffenburger DA, Wells A. IP-10 (CXCL10) can trigger emergence of dormant breast cancer cells in a metastatic liver microenvironment. Front Oncol. 2021;11:676135.","journal-title":"Front Oncol"},{"key":"8515_CR21","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1038\/s41388-020-01412-x","volume":"39","author":"B Lin","year":"2020","unstructured":"Lin B, Li Y, Wang T, Qiu Y, Chen Z, Zhao K, et al. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene. 2020;39:6024\u201340.","journal-title":"Oncogene"},{"key":"8515_CR22","first-page":"2710","volume":"60","author":"BA Pulaski","year":"2000","unstructured":"Pulaski BA, Terman DS, Khan S, Muller E, Ostrandrosenberg S. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res. 2000;60:2710\u20135.","journal-title":"Cancer Res"},{"key":"8515_CR23","doi-asserted-by":"crossref","unstructured":"Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2001;20:Unit20.2.","DOI":"10.1002\/0471142735.im2002s39"},{"key":"8515_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","volume":"4","author":"P Altea-Manzano","year":"2023","unstructured":"Altea-Manzano P, Doglioni G, Liu Y, Cuadros AM, Nolan E, Fernandez-Garcia J, et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-kappaB signaling. Nat Cancer. 2023;4:344\u201364.","journal-title":"Nat Cancer"},{"key":"8515_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8:1369\u201375.","journal-title":"Nat Cell Biol"},{"key":"8515_CR26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/ncb1794","volume":"10","author":"S Hiratsuka","year":"2008","unstructured":"Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol. 2008;10:1349\u201355.","journal-title":"Nat Cell Biol"},{"key":"8515_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/0008-5472.CAN-05-2502","volume":"66","author":"HB Acuff","year":"2006","unstructured":"Acuff HB. Matrix metalloproteinase-9 from bone marrow\u2013derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 2006;66:259\u201366.","journal-title":"Cancer Res"},{"key":"8515_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18:883\u201391.","journal-title":"Nat Med"},{"key":"8515_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41:546\u201372.","journal-title":"Cancer Cell"},{"key":"8515_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature16140","volume":"528","author":"SK Wculek","year":"2015","unstructured":"Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature. 2015;528:413\u20137.","journal-title":"Nature"},{"key":"8515_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1126\/sciimmunol.add5204","volume":"8","author":"Z Gong","year":"2023","unstructured":"Gong Z, Li Q, Shi J, Li P, Hua L, Shultz LD, et al. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Sci Immunol. 2023;8:20.","journal-title":"Sci Immunol"},{"key":"8515_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351.","journal-title":"Cell"},{"key":"8515_CR33","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/nar\/gkv1508","volume":"44","author":"U Jayachandran","year":"2016","unstructured":"Jayachandran U, Grey H, Cook AG. Nuclear factor 90 uses an ADAR2-like binding mode to recognize specific bases in dsRNA. Nucleic Acids Res. 2016;44:1924\u201336.","journal-title":"Nucleic Acids Res"},{"key":"8515_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4049\/jimmunol.180.1.222","volume":"180","author":"Y Pei","year":"2008","unstructured":"Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B, et al. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J Immunol. 2008;180:222\u20139.","journal-title":"J Immunol"},{"key":"8515_CR35","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1128\/MCB.00165-08","volume":"28","author":"Y Kuwano","year":"2008","unstructured":"Kuwano Y, Kim HH, Abdelmohsen K, Pullmann R Jr, Martindale JL, Yang X, et al. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol. 2008;28:4562\u201375.","journal-title":"Mol Cell Biol"},{"key":"8515_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41422-019-0257-1","volume":"30","author":"K Li","year":"2020","unstructured":"Li K, Wu JL, Qin B, Fan Z, Tang Q, Lu W, et al. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer. Cell Res. 2020;30:163\u201378.","journal-title":"Cell Res"},{"key":"8515_CR37","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"8515_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tips.2015.04.003","volume":"36","author":"S Gyoneva","year":"2015","unstructured":"Gyoneva S, Ransohoff RM. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol Sci. 2015;36:471\u201380.","journal-title":"Trends Pharmacol Sci"},{"key":"8515_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"key":"8515_CR40","doi-asserted-by":"crossref","unstructured":"Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev 2021;34:e00299-20.","DOI":"10.1128\/CMR.00163-21"},{"key":"8515_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett. 2011;2:583\u20139.","journal-title":"Oncol Lett"},{"key":"8515_CR42","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","volume":"30","author":"Y Hou","year":"2024","unstructured":"Hou Y, Yang K, Wang L, Wang J, Huang X, Piffko A, et al. Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites. Clin Cancer Res. 2024;30:1945\u201358.","journal-title":"Clin Cancer Res"},{"key":"8515_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15188-x","volume":"11","author":"M Pein","year":"2020","unstructured":"Pein M, Insua-Rodriguez J, Hongu T, Riedel A, Meier J, Wiedmann L, et al. Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020;11:1494.","journal-title":"Nat Commun"},{"key":"8515_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/wrna.1270","volume":"6","author":"S Castella","year":"2015","unstructured":"Castella S, Bernard R, Corno M, Fradin A, Larcher JC. Ilf3 and NF90 function in RNA biology. Wiley Interdiscip Rev RNA. 2015;6:243\u201356.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"8515_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818\u201322.","journal-title":"Science"},{"key":"8515_CR46","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s13238-020-00734-6","volume":"11","author":"N Sun","year":"2020","unstructured":"Sun N, Jiang L, Ye M, Wang Y, Wang G, Wan X, et al. TRIM35 mediates protection against influenza infection by activating TRAF3 and degrading viral PB2. Protein Cell. 2020;11:894\u2013914.","journal-title":"Protein Cell"},{"key":"8515_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.aao2300","volume":"360","author":"H Abe","year":"2018","unstructured":"Abe H, Jitsuki S, Nakajima W, Murata Y, Jitsuki-Takahashi A, Katsuno Y, et al. CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage. Science. 2018;360:50\u201357.","journal-title":"Science"},{"key":"8515_CR48","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1016\/j.apsb.2022.08.022","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, et al. New opportunities and challenges of natural products research: when target identification meets single-cell multiomics. Acta Pharm Sin B. 2022;12:4011\u201339.","journal-title":"Acta Pharm Sin B"},{"key":"8515_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154165","volume":"104","author":"M Jiang","year":"2022","unstructured":"Jiang M, Wang X, Lv B, Lu Y, Ma X, Liu W, et al. Psoralen induces hepatotoxicity by covalently binding to glutathione-S-transferases and the hepatic cytochrome P450. Phytomedicine. 2022;104:154165.","journal-title":"Phytomedicine"},{"key":"8515_CR50","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1007\/s12035-019-1568-4","volume":"56","author":"A Moutal","year":"2019","unstructured":"Moutal A, White KA, Chefdeville A, Laufmann RN, Vitiello PF, Feinstein D, et al. Dysregulation of CRMP2 Post-translational modifications drives its pathological functions. Mol Neurobiol. 2019;56:6736\u201355.","journal-title":"Mol Neurobiol"},{"key":"8515_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41419-022-05129-5","volume":"13","author":"Y Jin","year":"2022","unstructured":"Jin Y, Bian S, Wang H, Mo J, Fei H, Li L, et al. CRMP2 derived from cancer-associated fibroblasts facilitates progression of ovarian cancer via HIF-1\u03b1-glycolysis signaling pathway. Cell Death Dis. 2022;13:675.","journal-title":"Cell Death Dis"},{"key":"8515_CR52","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/biom11101533","volume":"11","author":"X Morales","year":"2021","unstructured":"Morales X, Pel\u00e1ez R, Garasa S, de Solorzano CO, Rouzaut A. CRMP2 as a candidate target to interfere with lung cancer cell migration. Biomolecules. 2021;11:1533.","journal-title":"Biomolecules"},{"key":"8515_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/j.pain.0000000000003357","volume":"166","author":"S Hestehave","year":"2025","unstructured":"Hestehave S, Allen HN, Gomez K, Duran P, Calderon-Rivera A, Loya-Lopez S, et al. Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model. Pain. 2025;166:13.","journal-title":"Pain"},{"key":"8515_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.104664","volume":"25","author":"HN Allen","year":"2024","unstructured":"Allen HN, Hestehave S, Duran P, Nelson TS, Khanna R. Uncoupling the CRMP2-CaV2.2 interaction reduces pain-like behavior in a preclinical joint-pain model. J Pain. 2024;25:104664.","journal-title":"J Pain"},{"key":"8515_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/biology9110385","volume":"9","author":"J Aseervatham","year":"2020","unstructured":"Aseervatham J. Cytoskeletal remodeling in cancer. Biology. 2020;9:385.","journal-title":"Biology"},{"key":"8515_CR56","doi-asserted-by":"crossref","unstructured":"Yoshihara S, Jiang X, Morikawa M, Ogawa T, Ichinose S, et al. Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport. Cell reports. 2021;35:108971.","DOI":"10.1016\/j.celrep.2021.108971"},{"key":"8515_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103665","volume":"84","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang J, Yin J, Ma W, Liao H, Ling L, et al. Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of ILF3. Redox Biol. 2025;84:103665.","journal-title":"Redox Biol"},{"key":"8515_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07562-8","volume":"16","author":"D Sun","year":"2025","unstructured":"Sun D, Cui X, Yang W, Wei M, Yan Z, Zhang M, et al. Simvastatin inhibits PD-L1 via ILF3 to induce ferroptosis in gastric cancer cells. Cell Death Dis. 2025;16:208.","journal-title":"Cell Death Dis"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08515-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:02:22Z","timestamp":1772812942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08515-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8515"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08515-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Breast tumor specimens and paired adjacent breast tissues were collected with the approval of the Institutional Ethics Review Boards of Jiangsu Province Hospital in accordance with the guidelines of the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS). Study approval was obtained from the ethical committees of Jiangsu Province Hospital (case number 2021-SR-308). Patients gave written informed consent. Autonomous consent free from coercion was obtained from the donor(s) or their next of kin, and the tissues were not sourced from executed prisoners or prisoners of conscience. All the animal experiments were approved by the Animal Ethics and Welfare Committee of Nanjing University of Chinese Medicine (202404A093) and complied with national and international guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"255"}}